Weimin Li
ORCID: 0000-0001-8846-793XAlso affiliated with Harbin Medical University, China Pharmaceutical University, Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, West China Medical Center of Sichuan University, Lanzhou Institute of Chemical Physics, West China Hospital of Sichuan University, Guizhou Minzu University, Guangdong Academy of Agricultural Sciences, General Hospital of Guangzhou Military Command, First Affiliated Hospital of Harbin Medical University, Hainan Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial”.
Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more
Zhen Zeng, Yang Jin, Lan Yang, Ting Fan, Zhoufeng Wang +14 more
Feng Chen, Qing Liu, Yongzhao Zhou, Yue Cheng, Panwen Tian +7 more